EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Amniotic fluid stem cell‐derived extracellular vesicles educate type 2 conventional dendritic cells to rescue autoimmune disorders in a multiple sclerosis mouse model

Giorgia Manni iD, Marco Gargaro, Doriana Ricciuti, Simona Fontana iD, Eleonora Padiglioni, Marco Cipolloni, Tommaso Mazza, Jessica Rosati, Alessandra di Veroli, Giulia Mencarelli, Benedetta Pieroni, Estevão Carlos Silva Barcelos und 11 weitere

Journal of Extracellular Vesicles · 2024

DOI: 10.1002/jev2.12446 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, 2024. Verfasst von Giorgia Manni und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Surgery, University of Perugia, Perugia, Italy. Hauptthemen laut MEDLINE: Extracellular Vesicles, Dendritic Cells, Amniotic Fluid, Encephalomyelitis, Autoimmune, Experimental. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Associazione Italiana per la Ricerca sul Cancro, Fondazione Telethon, PRIN.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dendritic cells (DCs) are essential orchestrators of immune responses and represent potential targets for immunomodulation in autoimmune diseases. Human amniotic fluid secretome is abundant in immunoregulatory factors, with extracellular vesicles (EVs) being a significant component. However, the impact of these EVs on dendritic cells subsets remain unexplored. In this study, we investigated the interaction between highly purified dendritic cell subsets and EVs derived from amniotic fluid stem cell lines (HAFSC‐EVs). Our results suggest that HAFSC‐EVs are preferentially taken up by conventional dendritic cell type 2 (cDC2) through CD29 receptor‐mediated internalization, resulting in a tolerogenic DC phenotype characterized by reduced expression and production of pro‐inflammatory mediators. Furthermore, treatment of cDC2 cells with HAFSC‐EVs in coculture systems resulted in a higher proportion of T cells expressing the regulatory T cell marker Foxp3 compared to vehicle‐treated control cells. Moreover, transfer of HAFSC‐EV‐treated cDC2s into an EAE mouse model resulted in the suppression of autoimmune responses and clinical improvement. These results suggest that HAFSC‐EVs may serve as a promising tool for reprogramming inflammatory cDC2s towards a tolerogenic phenotype and for controlling autoimmune responses in the central nervous system, representing a potential platform for the study of the effects of EVs in DC subsets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesDendritic CellsAmniotic FluidEncephalomyelitis, Autoimmune, ExperimentalDisease Models, AnimalMultiple SclerosisAnimalsMiceHumansFemaleStem CellsMice, Inbred C57BL

Stichwörter der Autor:innen

amniotic fluid stem cellsautoimmune diseasesconventional dendritic cell type 2 (cDC2)dendritic cellsexperimental autoimmune encephalomyelitis (EAE)extracellular vesiclestolerogenic phenotype

Autor:innen und Institutionen

  • Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
  • Extracellular Vesicles network (EV-net) of the University of Perugia, Perugia, Italy.
  • Department of Pharmaceutical Science, University of Perugia, Perugia, Italy.
  • Department of Biomedicine, Neurosciences and advanced Diagnostics (Bi.N.D) School of Medicine, University of Palermo, Palermo, Italy.
  • TES Pharma Srl, I, Corciano, Perugia, Italy.
  • Bioinformatics unit, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.

ORCID-Profile: Giorgia Manni, Simona Fontana

Förderung

  • Associazione Italiana per la Ricerca sul Cancro
  • Fondazione Telethon
  • PRIN
  • H2020 European Research Council
  • Fondazione Italiana Sclerosi Multipla
  • NextGenerationEU under the Italian MUR Vitality National Innovation Ecosystem grant
  • University of Perugia Azione di Ateneo 2022 "Regenia" to FF

Zitieren

APA

Manni, G., Gargaro, M., Ricciuti, D., Fontana, S., Padiglioni, E., Cipolloni, M., Mazza, T., Rosati, J., di Veroli, A., Mencarelli, G., Pieroni, B., Silva Barcelos, E. C., Scalisi, G., Sarnari, F., di Michele, A., Pascucci, L., de Franco, F., Zelante, T., Antognelli, C., …, & Fallarino, F. (2024). Amniotic fluid stem cell‐derived extracellular vesicles educate type 2 conventional dendritic cells to rescue autoimmune disorders in a multiple sclerosis mouse model. Journal of Extracellular Vesicles. https://doi.org/10.1002/jev2.12446

Vancouver

Manni G, Gargaro M, Ricciuti D, Fontana S, Padiglioni E, Cipolloni M, et al. Amniotic fluid stem cell‐derived extracellular vesicles educate type 2 conventional dendritic cells to rescue autoimmune disorders in a multiple sclerosis mouse model. Journal of Extracellular Vesicles. 2024. doi:10.1002/jev2.12446

BibTeX
@article{Manni2024,
  author = {Manni, Giorgia and Gargaro, Marco and Ricciuti, Doriana and Fontana, Simona and Padiglioni, Eleonora and Cipolloni, Marco and Mazza, Tommaso and Rosati, Jessica and di Veroli, Alessandra and Mencarelli, Giulia and Pieroni, Benedetta and Silva Barcelos, Estevão Carlos and Scalisi, Giulia and Sarnari, Francesco and di Michele, Alessandro and Pascucci, Luisa and de Franco, Francesca and Zelante, Teresa and Antognelli, Cinzia and Cruciani, Gabriele and Talesa, Vincenzo Nicola and Romani, Rita and Fallarino, Francesca},
  title = {Amniotic fluid stem cell‐derived extracellular vesicles educate type 2 conventional dendritic cells to rescue autoimmune disorders in a multiple sclerosis mouse model},
  journal = {Journal of Extracellular Vesicles},
  year = {2024},
  doi = {10.1002/jev2.12446}
}
Kostenlos starten →